Interestingly, our quantitative acetylproteomic results indicated that AMPK activation via metformin treatment significantly downregulated the acetylation levels at five lysine sites of NPM1 (K248, K202, K154, K229, and K141) in cervical cancer. This evidence concerns the gene NPM1 and cervical cancer.